DaCosta and Minden Labs Awarded CIHR Grant
https://dacostalab.ca/wp-content/uploads/2020/09/cihr-logo-1030x576.jpg 1030 576 DaCosta Lab DaCosta Lab https://dacostalab.ca/wp-content/uploads/2020/09/cihr-logo-1030x576.jpgDrs. Ralph DaCosta and Mark Minden have been awarded a 4-year CIHR Project Grant to identify new treatment options for acute myeloid leukemia (AML). AML is a disease of the bone marrow (BM) that spreads throughout the bones of affected patients. Interactions between AML cells and its surroundings play important protective and promotive functions…
read more